292 related articles for article (PubMed ID: 24169583)
1. Differences in methylation profiles between HPV-positive and HPV-negative oropharynx squamous cell carcinoma: a systematic review.
van Kempen PM; Noorlag R; Braunius WW; Stegeman I; Willems SM; Grolman W
Epigenetics; 2014 Feb; 9(2):194-203. PubMed ID: 24169583
[TBL] [Abstract][Full Text] [Related]
2. HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation.
van Kempen PM; van Bockel L; Braunius WW; Moelans CB; van Olst M; de Jong R; Stegeman I; van Diest PJ; Grolman W; Willems SM
Cancer Med; 2014 Oct; 3(5):1185-96. PubMed ID: 25065733
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic Mechanisms of Human Papillomavirus-Associated Head and Neck Cancer.
Anayannis NV; Schlecht NF; Belbin TJ
Arch Pathol Lab Med; 2015 Nov; 139(11):1373-8. PubMed ID: 25978766
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic changes in the CDKN2A locus are associated with differential expression of P16INK4A and P14ARF in HPV-positive oropharyngeal squamous cell carcinoma.
Schlecht NF; Ben-Dayan M; Anayannis N; Lleras RA; Thomas C; Wang Y; Smith RV; Burk RD; Harris TM; Childs G; Ow TJ; Prystowsky MB; Belbin TJ
Cancer Med; 2015 Mar; 4(3):342-53. PubMed ID: 25619363
[TBL] [Abstract][Full Text] [Related]
5. HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas.
Kostareli E; Holzinger D; Bogatyrova O; Hielscher T; Wichmann G; Keck M; Lahrmann B; Grabe N; Flechtenmacher C; Schmidt CR; Seiwert T; Dyckhoff G; Dietz A; Höfler D; Pawlita M; Benner A; Bosch FX; Plinkert P; Plass C; Weichenhan D; Hess J
J Clin Invest; 2013 Jun; 123(6):2488-501. PubMed ID: 23635773
[TBL] [Abstract][Full Text] [Related]
6. Frequent promoter hypermethylation associated with human papillomavirus infection in pharyngeal cancer.
Nakagawa T; Matsusaka K; Misawa K; Ota S; Takane K; Fukuyo M; Rahmutulla B; Shinohara KI; Kunii N; Sakurai D; Hanazawa T; Matsubara H; Nakatani Y; Okamoto Y; Kaneda A
Cancer Lett; 2017 Oct; 407():21-31. PubMed ID: 28823962
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of EZH2 inhibitory drugs in human papillomavirus-positive and human papillomavirus-negative oropharyngeal squamous cell carcinomas.
Lindsay CD; Kostiuk MA; Harris J; O'Connell DA; Seikaly H; Biron VL
Clin Epigenetics; 2017; 9():95. PubMed ID: 28878842
[TBL] [Abstract][Full Text] [Related]
8. Stratification of HPV-associated and HPV-negative oropharyngeal squamous cell carcinomas based on DNA methylation epigenotypes.
Nakagawa T; Matsusaka K; Misawa K; Ota S; Fukuyo M; Rahmutulla B; Kunii N; Sakurai D; Hanazawa T; Matsubara H; Okamoto Y; Kaneda A
Int J Cancer; 2020 May; 146(9):2460-2474. PubMed ID: 31997344
[TBL] [Abstract][Full Text] [Related]
9. Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.
Ren S; Gaykalova D; Wang J; Guo T; Danilova L; Favorov A; Fertig E; Bishop J; Khan Z; Flam E; Wysocki PT; DeJong P; Ando M; Liu C; Sakai A; Fukusumi T; Haft S; Sadat S; Califano JA
Int J Cancer; 2018 Nov; 143(10):2425-2436. PubMed ID: 30070359
[TBL] [Abstract][Full Text] [Related]
10. IGSF4 methylation as an independent marker of human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Chen KM; Stephen JK; Havard S; Mahan M; Divine G; Worsham MJ
JAMA Otolaryngol Head Neck Surg; 2015 Mar; 141(3):257-63. PubMed ID: 25569158
[TBL] [Abstract][Full Text] [Related]
11. AKR1C3 is a biomarker and druggable target for oropharyngeal tumors.
Peraldo-Neia C; Ostano P; Mello-Grand M; Guana F; Gregnanin I; Boschi D; Oliaro-Bosso S; Pippione AC; Carenzo A; De Cecco L; Cavalieri S; Micali A; Perrone F; Averono G; Bagnasacco P; Dosdegani R; Masini L; Krengli M; Aluffi-Valletti P; Valente G; Chiorino G
Cell Oncol (Dordr); 2021 Apr; 44(2):357-372. PubMed ID: 33211282
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of copy number profiling in oral and oropharyngeal squamous cell carcinoma.
van Kempen PM; Noorlag R; Braunius WW; Moelans CB; Rifi W; Savola S; Koole R; Grolman W; van Es RJ; Willems SM
Cancer Med; 2015 Oct; 4(10):1525-35. PubMed ID: 26194878
[TBL] [Abstract][Full Text] [Related]
13. Chromatin structure regulates cancer-specific alternative splicing events in primary HPV-related oropharyngeal squamous cell carcinoma.
Guo T; Zambo KDA; Zamuner FT; Ou T; Hopkins C; Kelley DZ; Wulf HA; Winkler E; Erbe R; Danilova L; Considine M; Sidransky D; Favorov A; Florea L; Fertig EJ; Gaykalova DA
Epigenetics; 2020 Sep; 15(9):959-971. PubMed ID: 32164487
[TBL] [Abstract][Full Text] [Related]
14. Human papilloma virus (HPV) modulation of the HNSCC epigenome.
Stephen JK; Worsham MJ
Methods Mol Biol; 2015; 1238():369-79. PubMed ID: 25421671
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation using 24-gene array in early head and neck cancer: better outcome in oral than in oropharyngeal cancer.
Noorlag R; van Kempen PM; Moelans CB; de Jong R; Blok LE; Koole R; Grolman W; van Diest PJ; van Es RJ; Willems SM
Epigenetics; 2014 Sep; 9(9):1220-7. PubMed ID: 25147921
[TBL] [Abstract][Full Text] [Related]
16. A functional variant at the miRNA binding site in E2F1 gene is associated with risk and tumor HPV16 status of oropharynx squamous cell carcinoma.
Yuan Y; Sturgis EM; Zhu L; Lu M; Li Y; Wei Q; Li G
Mol Carcinog; 2017 Mar; 56(3):1100-1106. PubMed ID: 27677255
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH
Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631
[TBL] [Abstract][Full Text] [Related]
18. Investigation of EZH2 pathways for novel epigenetic treatment strategies in oropharyngeal cancer.
Idris S; Lindsay C; Kostiuk M; Andrews C; Côté DW; O'Connell DA; Harris J; Seikaly H; Biron VL
J Otolaryngol Head Neck Surg; 2016 Oct; 45(1):54. PubMed ID: 27793210
[TBL] [Abstract][Full Text] [Related]
19. The molecular differences between human papillomavirus-positive and -negative oropharyngeal squamous cell carcinoma: A bioinformatics study.
Wang J; Xi X; Shang W; Acharya A; Li S; Savkovic V; Li H; Haak R; Schmidt J; Liu X; Deng Y; Pan H; Obradovic D; Schmalz G; Ziebolz D; Hu X
Am J Otolaryngol; 2019; 40(4):547-554. PubMed ID: 31036418
[TBL] [Abstract][Full Text] [Related]
20. The molecular mechanisms of increased radiosensitivity of HPV-positive oropharyngeal squamous cell carcinoma (OPSCC): an extensive review.
Liu C; Mann D; Sinha UK; Kokot NC
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):59. PubMed ID: 30241572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
